NOBEL PHARM PLUS

Pharmacovigilance

A strong commitment to patient safety through continuous and structured monitoring of medicinal products.

Our Mission

The mission of the Pharmacovigilance Division is to safeguard public health by ensuring the safe and appropriate use of medicinal products throughout their entire lifecycle.

The department continuously monitors, documents, evaluates, and reports suspected adverse reactions related to medicinal products distributed by Nobel Pharm Plus, in full compliance with European pharmacovigilance legislation and applicable regulatory requirements.

Through ongoing safety surveillance and scientific assessment, the division enables the early identification of potential risks and supports timely regulatory and risk-minimisation actions.

Reporting suspected side effects is essential to continuously improve the safety profile of medicines.